Selective decontamination of the digestive tract. 2008

Anne Marie G A de Smet, and Marc J M Bonten
Department of Anaesthesiology, Division of Perioperative and Emergency Care, University Medical Center Utrecht, The Netherlands.

OBJECTIVE The aim of this article is to review relevant studies on the topic of selective decontamination of the digestive tract published in 2006 and 2007. RESULTS The only recently published randomized controlled selective decontamination of the digestive tract study failed to demonstrate a benefit of selective decontamination on survival among trauma patients. In fact, two new meta-analyses of selective decontamination of the digestive tract studies were presented: one demonstrated reduced incidences of Gram-negative bacteraemia; in the other no reduction in fungaemia was found. Although selective decontamination of the digestive tract has been associated with increased selection of methicillin-resistant Staphylococcus aureus (MRSA), transmission of MRSA was controlled in a Spanish unit when using selective decontamination in combination with topical vancomycin. Several randomized studies and one meta-analysis suggest that oropharyngeal decontamination with antiseptics is also highly effective in preventing respiratory tract infection in critically ill patients. CONCLUSIONS The evidence that selective decontamination of the digestive tract improves patient outcome in mixed ICU patients is still based upon meta-analysis and two single centre studies in MRSA-naïve settings. Larger and preferably multicentre studies are needed to confirm these observations. Further remaining questions are whether oropharyngeal decontamination alone is as effective as the full selective decontamination of the digestive tract regimen and whether selective decontamination could be applied successfully in settings with high levels of antibiotic resistance.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D003666 Decontamination The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D014947 Wounds and Injuries Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. Injuries,Physical Trauma,Trauma,Injuries and Wounds,Injuries, Wounds,Research-Related Injuries,Wounds,Wounds and Injury,Wounds, Injury,Injury,Injury and Wounds,Injury, Research-Related,Physical Traumas,Research Related Injuries,Research-Related Injury,Trauma, Physical,Traumas,Wound
D015201 Meta-Analysis as Topic A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine. Clinical Trial Overviews,Data Pooling,Overviews, Clinical Trial,Clinical Trial Overview,Data Poolings,Meta Analysis as Topic,Overview, Clinical Trial
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D041981 Gastrointestinal Tract Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS). Digestive Tract,GI Tract,Digestive Tracts,GI Tracts,Gastrointestinal Tracts
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Anne Marie G A de Smet, and Marc J M Bonten
October 2010, Enfermedades infecciosas y microbiologia clinica,
Anne Marie G A de Smet, and Marc J M Bonten
November 1991, Lancet (London, England),
Anne Marie G A de Smet, and Marc J M Bonten
July 1992, The New England journal of medicine,
Anne Marie G A de Smet, and Marc J M Bonten
July 1992, The New England journal of medicine,
Anne Marie G A de Smet, and Marc J M Bonten
December 1989, BMJ (Clinical research ed.),
Anne Marie G A de Smet, and Marc J M Bonten
February 1994, BMJ (Clinical research ed.),
Anne Marie G A de Smet, and Marc J M Bonten
April 2002, Current opinion in critical care,
Anne Marie G A de Smet, and Marc J M Bonten
January 1990, BMJ (Clinical research ed.),
Anne Marie G A de Smet, and Marc J M Bonten
February 1990, BMJ (Clinical research ed.),
Anne Marie G A de Smet, and Marc J M Bonten
May 1993, Annals of internal medicine,
Copied contents to your clipboard!